CSF3 and Duchenne muscular dystrophy: We found significant (p = 0.001) increase of forced vital capacity in patients with DMD after fifth cycle of G-CSF treatment (1.69 ± 0.44 L) in comparison with the baseline (1.54 ± 0.43 L).